News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Pathologists in Canada Address Handling and Use of Tissue Specimens for Clinical Diagnostic Purposes at IQMH Conference in Toronto

Variability in how tissue is handled from one histopathology laboratory to another greatly affects quality of specimen and accuracy of the pathologist’s diagnosis

TORONTO, ONTARIO, CANADA—Here on the shores of Lake Ontario, pathologists and clinical laboratory professionals gathered last week for a unique conference that focused on quality issues involving how tissue is handled from collection and transport to the histopathology laboratory processing to diagnosis by surgical pathologists.

Your Dark Daily editor was here to participate in the conference and learn from a first-rank panel of speakers. As many long-time readers know, patients, physicians, and health insurers expect increasingly higher levels of accuracy in how lab specimens are handled and greater precision in the resulting diagnosis that is produced by pathologists. Thus, a conference dedicated to tissue specimen integrity and quality is both timely and appropriate. (more…)

Medical Laboratory Leaders Gather in the United Kingdom to Address Challenges of Shrinking Lab Budgets and Need to Upgrade Quality Assurance Performance

Nation’s healthcare system is in the midst of major clinical, organizational, and financial reforms—many of which require immediate responses by pathology laboratories

BIRMINGHAM, England—Two major challenges in laboratory medicine were front and center this week when medical laboratory, a professionals and histopathologists gathered here in the United Kingdom (UK) for the eleventh annual Frontiers in Laboratory Medicine (FiLM).

One challenge is how to improve the quality of lab testing services and demonstrate value to payers. The other challenge is how medical laboratories in the UK  can cope with shrinking budgets for medical laboratories. (more…)

Pathology Laboratories in the United Kingdom to Be Challenged by New Reimbursement Models and the NHS’ Latest Call for Faster Innovation

Pathologists and medical laboratory managers will take up these issues at the upcoming Frontiers in Laboratory Medicine Conference in Birmingham, England on January 29-30, 2013

Medical laboratory testing in the United Kingdom is experiencing change at an accelerating rate. These changes reflect ongoing reforms within the National Health System (NHS), which is itself dealing with increased demand for healthcare services in the face of limited budgets.

That means providers in the United Kingdom—including pathology laboratories—are being asked to deliver more clinical services even as budgets are held constant or even reduced. There are also calls for all providers of clinical services to become more innovative in ways that improve the quality of patient services while reducing the overall cost of care. (more…)

Why Hospital Implementation of an Enterprise-Wide EMR Can Often “Degrade” the Informatics Capabilities of the Clinical Laboratory

Hospital’s purchase of an “enterprise-wide solution” to be the EMR and related ancillary system software often leaves the hospital lab without the full LIS functions found in best-of-breed LIS products

DATELINE—PITTSBURGH, PENNSYLVANIA, Part II: Adoption of electronic medical record (EMR) systems by hospitals and health systems throughout this country may now be the single most disruptive factor in how hospital labs configure their laboratory information systems (LIS) specifically in support of their parent institutions’ informatics requirements.

This issue surfaced repeatedly during presentations made here on Friday, June 8, at the Strategic Summit organized by the Association for Pathology Informatics (API). In simplest terms, a growing number of hospital and health system administrators want to purchase and deploy a single “enterprise-wide solution” (EWS) for their EMR and total informatics needs. (more…)

LabCorp to Buy MEDTOX Scientific, Inc., for $241 Million

More consolidation in the clinical laboratory and pathology testing industry

It was announced yesterday that MEDTOX Scientific, Inc. (NASDAQ:MTOX), of New Brighton, Minnesota, will be acquired by Laboratory Corporation of America (NYSE:LH) of Burlington, North Carolina. The purchase price is approximately $241 million and represents a 37% premium over Medtox’s closing price of $19.70 on Friday, June 1.

Significantly, LabCorp’s purchase of MEDTOX removes one more independent laboratory company from the market. This continues the trend of medical laboratory consolidation that has marked the lab testing industry for the past 25 years. (more…)

;